Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Adamis Pharmaceuticals Corporation
Sponsor:
Information provided by (Responsible Party):
Adamis Pharmaceuticals Corporation
ClinicalTrials.gov Identifier:
NCT01436214
First received: August 31, 2011
Last updated: January 22, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)